Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp55408_8k.htm |
Exhibit 99.1
|
Press Release
www.shire.com
|
 |
Shire to announce first quarter 2015 results
Dublin, Ireland – April 21, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG), will announce first quarter 2015 earnings on Thursday April 30, 2015.
|
Results press release will be issued at:
|
12:00 BST / 07:00 EDT
|
|
Investor conference call time:
|
14:00 BST / 09:00 EDT
|
Live conference call for investors:
Flemming Ornskov, Chief Executive Officer and Jeff Poulton, Interim Chief Financial Officer will host the investor and analyst conference call at 14:00 BST/9:00 EDT.
The details of the conference call are as follows:
|
UK dial in:
|
0808 237 0030 or 020 3139 4830
|
|
US dial in:
|
1 866 928 7517 or 1 718 873 9077
|
|
International Access Numbers:
|
Click here
|
|
Password/Conf ID:
|
54094197#
|
|
Live Webcast:
|
Click here
|
Replay:
A replay of the presentation will be available for two weeks by phone and by webcast for three months. Details can be found on our Investor Relations website http://www.shire.com/shireplc/en/investors.
For further information please contact:
|
Investor Relations
|
||
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX